{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T17:45:40Z","timestamp":1762451140786,"version":"build-2065373602"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,7,10]],"date-time":"2020-07-10T00:00:00Z","timestamp":1594339200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Regenerative Therapy"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.reth.2020.05.005","type":"journal-article","created":{"date-parts":[[2020,7,31]],"date-time":"2020-07-31T06:39:34Z","timestamp":1596177574000},"page":"112-120","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["The integrity of chemically treated plasmid DNA as a chemical-based choice for prion clearance"],"prefix":"10.1016","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9360-8597","authenticated-orcid":false,"given":"Nozomi","family":"Takada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1659-2149","authenticated-orcid":false,"given":"Yasuharu","family":"Niwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoaki","family":"Teshigawara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazue","family":"Isogai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanayuki","family":"Okura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akifumi","family":"Matsuyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.reth.2020.05.005_bib1","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1348-0421.1991.tb01544.x","article-title":"Practical methods for chemical inactivation of Creutzfeldt-Jakob disease pathogen","volume":"35","author":"Tateishi","year":"1991","journal-title":"Microbiol Immunol"},{"year":"2014","series-title":"Notification No.375 of the Ministry of Health, Labour and Welfare of Japan, Established on September 26","key":"10.1016\/j.reth.2020.05.005_bib2"},{"year":"2014","series-title":"Regarding the implementation of the standards for biological ingredients","key":"10.1016\/j.reth.2020.05.005_bib3"},{"key":"10.1016\/j.reth.2020.05.005_bib4","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1146\/annurev.neuro.24.1.519","article-title":"Prion diseases of humans and animals: their causes and molecular basis","volume":"24","author":"Collinge","year":"2001","journal-title":"Annu Rev Neurosci"},{"issue":"4","key":"10.1016\/j.reth.2020.05.005_bib5","doi-asserted-by":"crossref","first-page":"483","DOI":"10.3892\/ijmm.2011.605","article-title":"Fundamentals of prions and their inactivation (Review)","volume":"27","author":"Sakudo","year":"2011","journal-title":"Int J Mol Med"},{"issue":"3","key":"10.1016\/j.reth.2020.05.005_bib6","doi-asserted-by":"crossref","first-page":"E261","DOI":"10.3390\/v11030261","article-title":"Prion and prion-like protein strains: deciphering the molecular basis of heterogeneity in neurodegeneration","volume":"11","author":"Scialo","year":"2019","journal-title":"Viruses"},{"issue":"2","key":"10.1016\/j.reth.2020.05.005_bib7","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1086\/650197","article-title":"Guideline for disinfection and sterilization of prion-contaminated medical instruments","volume":"31","author":"Rutala","year":"2010","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"9","key":"10.1016\/j.reth.2020.05.005_bib8","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1086\/319997","article-title":"Creutzfeldt-Jakob disease: recommendations for disinfection and sterilization","volume":"32","author":"Rutala","year":"2001","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.reth.2020.05.005_bib9","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/ana.410240325","article-title":"Inactivation of the Creutzfeldt-Jakob disease agent","volume":"24","author":"Tateishi","year":"1988","journal-title":"Annu Neurol"},{"issue":"2","key":"10.1016\/j.reth.2020.05.005_bib10","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1007\/s11356-013-1949-6","article-title":"In\u00a0vitro cytogenetic assessment of trichloroacetic acid in human peripheral blood lymphocytes","volume":"21","author":"Varshney","year":"2014","journal-title":"Environ Sci Pollut Res Int"},{"key":"10.1016\/j.reth.2020.05.005_bib11","first-page":"287","article-title":"Prion disease -the characteristics and diagnostic points in Japan-","volume":"50","author":"Sanjo","year":"2010","journal-title":"Clin Neurol"},{"issue":"9","key":"10.1016\/j.reth.2020.05.005_bib12","first-page":"231","article-title":"Current situation of prion risks on blood products","volume":"59","author":"Kato-Mori","year":"2013"},{"year":"2008","series-title":"Guideline for preventing prion disease infection","key":"10.1016\/j.reth.2020.05.005_bib13"},{"issue":"1","key":"10.1016\/j.reth.2020.05.005_bib14","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1099\/jgv.0.001335","article-title":"Eliminating transmissibility of bovine spongiform encephalopathy by dry-heat treatment","volume":"101","author":"Matsuura","year":"2020","journal-title":"J\u00a0Gen Virol"},{"issue":"5","key":"10.1016\/j.reth.2020.05.005_bib15","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1111\/tbed.13247","article-title":"Incomplete inactivation of atypical scrapie following recommended autoclave decontamination procedures","volume":"66","author":"Spiropoulos","year":"2019","journal-title":"Transbound Emerg Dis"},{"issue":"10","key":"10.1016\/j.reth.2020.05.005_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0223659","article-title":"Inactivation of chronic wasting disease prions using sodium hypochlorite","volume":"14","author":"Williams","year":"2019","journal-title":"PloS One"},{"issue":"2","key":"10.1016\/j.reth.2020.05.005_bib17","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jhin.2006.06.007","article-title":"Quantitative evaluation of prion inactivation comparing steam sterilization and chemical sterilants: proposed method for test standardization","volume":"64","author":"Vadrot","year":"2006","journal-title":"J\u00a0Hosp Infect"},{"issue":"9433","key":"10.1016\/j.reth.2020.05.005_bib18","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0140-6736(04)16810-4","article-title":"Novel methods for disinfection of prion-contaminated medical devices","volume":"364","author":"Fichet","year":"2004","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.reth.2020.05.005_bib19","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/j.1365-2516.2007.01441.x","article-title":"Transmissible spongiform encephalopathy agent clearance by the immunoaffinity and anion-exchange chromatography steps of ReFacto manufacturing process","volume":"13","author":"Booth","year":"2007","journal-title":"Haemophilia"},{"issue":"4","key":"10.1016\/j.reth.2020.05.005_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0122300","article-title":"Removal of transmissible spongiform encephalopathy prion from large volumes of cell culture media supplemented with fetal bovine serum by using hollow fiber anion-exchange membrane chromatography","volume":"10","author":"Chou","year":"2015","journal-title":"PloS One"}],"container-title":["Regenerative Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352320420300572?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352320420300572?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T17:40:13Z","timestamp":1762450813000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352320420300572"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":20,"alternative-id":["S2352320420300572"],"URL":"https:\/\/doi.org\/10.1016\/j.reth.2020.05.005","relation":{},"ISSN":["2352-3204"],"issn-type":[{"type":"print","value":"2352-3204"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The integrity of chemically treated plasmid DNA as a chemical-based choice for prion clearance","name":"articletitle","label":"Article Title"},{"value":"Regenerative Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.reth.2020.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Japanese Society for Regenerative Medicine. Production and hosting by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}